Stone Ridge Asset Management LLC Buys 67,600 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Stone Ridge Asset Management LLC increased its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 57.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 185,870 shares of the pharmacy operator’s stock after acquiring an additional 67,600 shares during the quarter. Walgreens Boots Alliance makes up 0.6% of Stone Ridge Asset Management LLC’s investment portfolio, making the stock its 22nd largest position. Stone Ridge Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $10,162,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently bought and sold shares of WBA. LSV Asset Management lifted its stake in shares of Walgreens Boots Alliance by 0.9% in the 1st quarter. LSV Asset Management now owns 11,672,531 shares of the pharmacy operator’s stock valued at $738,521,000 after purchasing an additional 107,600 shares during the period. Geode Capital Management LLC lifted its stake in shares of Walgreens Boots Alliance by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock valued at $786,522,000 after purchasing an additional 834,241 shares during the period. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Walgreens Boots Alliance by 11.4% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 10,667,865 shares of the pharmacy operator’s stock valued at $674,956,000 after purchasing an additional 1,093,610 shares during the period. Nordea Investment Management AB lifted its stake in shares of Walgreens Boots Alliance by 2.0% in the 1st quarter. Nordea Investment Management AB now owns 7,679,640 shares of the pharmacy operator’s stock valued at $485,896,000 after purchasing an additional 148,814 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Walgreens Boots Alliance by 263.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 3,306,439 shares of the pharmacy operator’s stock valued at $209,198,000 after purchasing an additional 2,396,640 shares during the period. Institutional investors and hedge funds own 62.03% of the company’s stock.

A number of research firms have recently commented on WBA. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Monday, June 24th. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a research note on Friday. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price for the company. in a research note on Monday, June 10th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. Finally, Bank of America lowered their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research note on Monday, June 3rd. Six analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $63.65.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the transaction, the chief accounting officer now owns 357,851 shares in the company, valued at $18,064,318.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 15.73% of the stock is currently owned by insiders.

NASDAQ:WBA traded down $1.63 during trading hours on Friday, reaching $49.32. 4,700,031 shares of the company traded hands, compared to its average volume of 4,614,057. The business’s 50-day moving average price is $53.61 and its two-hundred day moving average price is $57.04. The stock has a market capitalization of $45.97 billion, a P/E ratio of 8.19, a P/E/G ratio of 1.27 and a beta of 0.81. Walgreens Boots Alliance Inc has a 1 year low of $49.12 and a 1 year high of $86.31. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.05. The business had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The firm’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.53 earnings per share. As a group, equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th will be paid a dividend of $0.458 per share. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a yield of 3.71%. Walgreens Boots Alliance’s payout ratio is presently 30.40%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: What is a growth and income fund?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.